Publications Office of the EU
Poland-Bydgoszcz: Medicinal products for the alimentary tract and metabolism - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Poland-Bydgoszcz: Medicinal products for the alimentary tract and metabolism

  • Awarded
    30/12/2022
  • Today
    06/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Wojewódzki Szpital Dziecięcy im. J. Brudzińskiego w Bydgoszczy
Place of performance
NUTS code: PL911 Miasto Warszawa
Location of buyer
NUTS code: PL613 Bydgosko-Toruński
Business sector (Main CPV)
33610000 Medicinal products for the alimentary tract and metabolism
Total estimated contract value (excluding VAT)
4,781,610.80
Total final contract value (excluding VAT)
4,781,610.80 PLN
Tender reference number
53/2022/WR
Description

Przedmiotem zamówienia są sukcesywne dostawy leków stosowanego w programie leczenia mukopolisacharydozy typu II -Zespół Huntera : Idursulfase (Elaprase)

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Lowest price
Estimated value
4,781,610.80
Final contracted value
4,781,610.80 PLN
Award of contract
Official name: Takeda Pharma Sp. z o.o.
Postal address: ul.Prosta
Town: Warszawa
Postal code: 00-838
Country: POL
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.